Improving Alzheimer's Disease Treatment by Understanding APOE and AANCR
A comprehensive study of APOE and the noncoding RNA AANCR to advance Alzheimer’s Disease treatment
This project explores how a gene called APOE and a noncoding RNA called AANCR work together to find new ways to treat Alzheimer's Disease, especially for people with the APOE4 gene.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11195562 on NIH RePORTER |
What this research studies
This research focuses on APOE4, a significant genetic factor that increases the risk of Alzheimer's Disease for millions worldwide. Despite extensive efforts, there are currently no specific treatments tailored for individuals with the APOE4 gene. Our team recently discovered a key noncoding RNA, AANCR, that helps regulate APOE, and we believe understanding this relationship is crucial. By thoroughly investigating how APOE expression and function are controlled, we aim to pave the way for precise gene therapies, such as those using mRNA or antisense oligonucleotides, to target APOE4 and potentially prevent or treat Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for future related studies might be individuals with Alzheimer's Disease who carry the APOE4 gene, or those at high risk due to this genetic factor.
Not a fit: Patients whose Alzheimer's Disease is not linked to the APOE4 gene may not directly benefit from treatments specifically targeting this pathway.
Why it matters
Potential benefit: If successful, this work could lead to new, targeted gene therapies for Alzheimer's Disease, particularly for individuals with the APOE4 genetic risk factor.
How similar studies have performed: While gene therapy breakthroughs offer hope, precision medicine specifically targeting APOE4 for Alzheimer's is a critical unmet need, making this approach novel and largely untested in this specific context.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Cheung, Vivian G — Brown University
- Study coordinator: Cheung, Vivian G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.